| 000 | 00944 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250514164427.0 | ||
| 264 | 0 | _c20040517 | |
| 008 | 200405s 0 0 eng d | ||
| 022 | _a1364-6745 | ||
| 024 | 7 |
_a10.1007/s10048-003-0170-z _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVoncken, Max | |
| 245 | 0 | 0 |
_aFriedreich ataxia-update on pathogenesis and possible therapies. _h[electronic resource] |
| 260 |
_bNeurogenetics _cFeb 2004 |
||
| 300 |
_a1-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntioxidants _xtherapeutic use |
| 650 | 0 | 4 |
_aFriedreich Ataxia _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIron Chelating Agents _xtherapeutic use |
| 700 | 1 | _aIoannou, Panos | |
| 700 | 1 | _aDelatycki, Martin B | |
| 773 | 0 |
_tNeurogenetics _gvol. 5 _gno. 1 _gp. 1-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10048-003-0170-z _zAvailable from publisher's website |
| 999 |
_c14420591 _d14420591 |
||